|
||
Article |
Correspondence to Takayuki Michikawa: takamich{at}ims.u-tokyo.ac.jp; or Katsuhiko Mikoshiba: mikosiba{at}ims.u-tokyo.ac.jp
|
|
|---|
| Introduction |
|---|
|
|
|---|
Stimulus-induced cytosolic Ca2+ spikes usually form as a result of an initial slow pacemaker rise in [Ca2+]c followed by a rapid rise in [Ca2+]c (Jacob et al., 1988; Thomas et al., 1991; Bootman and Berridge, 1996). The rate of the rapid [Ca2+]c rise remains relatively constant regardless of the stimulus intensity (Cobbold et al., 1991; Thomas et al., 1991), suggesting that a regenerative process is involved in the generation of the abrupt upstroke (Thomas et al., 1991). Such regenerative processes require a positive-feedback element (Meyer and Stryer, 1991), and some molecules that are critical to the regenerative process have been proposed. PLC catalyzes the formation of inositol 1,4,5-trisphosphate (IP3) and diacylglycerol from phosphatidylinositol 4,5-bisphosphate and has been hypothesized to act as a positive-feedback element (Meyer and Stryer, 1988; Harootunian et al., 1991) because its activity is stimulated by cytosolic Ca2+ (Rebecchi and Pentyala, 2000). According to their hypothesis, the positive-feedback regulation of PLC by cytosolic Ca2+ allows generation of IP3 spikes that result in Ca2+ spikes through activation of the IP3 receptor (IP3R)/IP3-gated Ca2+ release channel (Meyer and Stryer, 1988). Another hypothesis is that the positive-feedback regulation is attributable to the intrinsic property of the IP3R. The biphasic dependency of channel activity on Ca2+ (Iino, 1990) may create the rapid upstroke of Ca2+ spikes even at constant levels of IP3 (Wakui et al., 1989; Osipchuk et al., 1990; Wakui et al., 1990; Dupont et al., 1991; De Young and Keizer, 1992; Hajnoczky and Thomas, 1997). These mechanisms for the generation of Ca2+ spikes, however, are not necessarily exclusive, and combined models are also plausible.
Observation of cytosolic IP3 dynamics during Ca2+ spikes should help us better understand the mechanism responsible for the Ca2+ spike generation (Meyer and Stryer, 1991). The GFP-tagged pleckstrin homology domain (PHD) of PLC-
1, which interacts with phosphatidylinositol 4,5-bisphosphate and/or IP3, has been used to monitor IP3 production and its oscillatory translocation from plasma membrane to the cytosol synchronously with Ca2+ oscillation was observed in MDCK cells (Hirose et al., 1999), suggesting that each Ca2+ spike accompanies IP3 production. However, there is no simple correlation between its translocation from the plasma membrane to the cytosol and actual cytosolic [IP3] ([IP3]c van der Wal et al., 2001; Xu et al., 2003; Irvine, 2004). Fluorescent IP3 sensors based on the IP3 binding domain of IP3R have recently been developed (Tanimura et al., 2004; Sato et al., 2005; Remus et al., 2006), but no one has ever used them to investigate the mechanism underlying the Ca2+ spike generation in living cells.
In the present study, we developed low IP3 binding affinity, high signal-to-noise ratio cytosolic IP3 sensors based on the IP3 binding domain of mouse type 1 IP3R (IP3R1) and used them to analyze the mechanism responsible for the generation of Ca2+ oscillations. Simultaneous imaging of [Ca2+]c and [IP3]c in living cells exposed to extracellular stimuli provided us with a novel insight into the mechanism of generation of intracellular Ca2+ spikes.
| Results |
|---|
|
|
|---|
|
IRIS-1 was uniformly distributed within the cytosol of intact HeLa cells (Fig. 2 A), and
80% of IRIS-1 was released from the cells after 5 min of treatment with 0.1% saponin (Fig. 2, A and B
). ECFP-tagged IP3R1, which is an ER resident protein, was hardly released from the cells with the same treatment (Fig. 2, A and B). These results indicate that IRIS-1 is mainly localized in the cytosol of HeLa cells. To monitor cytosolic IP3 and Ca2+ dynamics simultaneously, Indo-1 was loaded into IRIS-1expressing HeLa cells. Fig. 2 D shows FRET changes of IRIS-1 accompanied by Ca2+ transients (Fig. 2 C) elicited by sequential stimulations with 1, 5, and 10 µM of histamine. We did not detect FRET changes in IRIS-1Dmutexpressing cells even when Ca2+ transients were observed (Fig. 2, E and F), and the expression level of IRIS-1Dmut was indistinguishable from that of IRIS-1 (Fig. 2 G). FRET changes of IRIS-1 were completely blocked by the addition of 10 µM of PLC inhibitor U73122 but not by its inactive analogue U73343 in (Fig. S1, A and B, available at http://www.jcb.org/cgi/content/full/jcb.200512141/DC1). These results indicate that IRIS-1 can monitor [IP3]c changes in living cells.
|
|
|
We did not detect IP3 spikes, i.e., rapid upstrokes of [IP3]c with a constant amplitude followed by a gradual decrease of [IP3]c to its basal level, even when Ca2+ spikes were triggered by glutamate (Fig. 4 A) or histamine application (Fig. 4 B). However, if the IP3 sensor was saturated with IP3 in the cells and/or the FRET change of IRIS-1 upon IP3 binding was too slow to detect [IP3]c changes, we would have missed the IP3 spikes, so we conducted the following experiments to investigate these possibilities. IRIS-1expressing HeLa cells were permeabilized with 60 µM ß-escin for 3 min and then exposed to solutions containing various concentrations of IP3. IRIS-1 exhibited a maximal response of 28.0% after addition of an excess amount of IP3 under the conditions used (Fig. S1 C). The maximal response observed was greater than that observed in intact cells stimulated with 100 µM glutamate (
20%; Fig. 4 A) and 3 µM histamine (
7%; Fig. 4 B), indicating that the dynamic range of changes in the IRIS-1 signals is greater than the changes in [IP3]c evoked by the stimuli when the resting level of [IP3]c is sufficiently low (<100 nM). The possibility of saturation of the IRIS-1 signals was further investigated with IRIS-1.2, a low-affinity mutant of IRIS-1 in which lysine 249 is replaced by glutamine (K249Q). IRIS-1.2 exhibited approximately sevenfold lower affinity for IP3 than IRIS-1 (Fig. S1 D). FRET signals observed with IRIS-1.2 revealed temporal patterns similar to those observed with IRIS-1 during Ca2+ oscillations evoked by mGluR5a stimulation (Fig. S1, E and F). The IRIS-1.2 signals rapidly rose after the addition of glutamate, and they remained at the elevated level and underwent fluctuations (but not baseline spikes) during Ca2+ oscillations. These results indicate that the IRIS-1 signals in intact cells were not saturated when the mGluR5a-expressing HeLa cells were stimulated with 100 µM glutamate. The rate of changes in IRIS-1 signals was evaluated directly by measurements of the fluorescent changes of IRIS-1 after rapid mixing with IP3 using stopped-flow fluorescence spectrometry (see the supplemental text and Fig. S2, available at http://www.jcb.org/cgi/content/full/jcb.200512141/DC1). The analysis of the kinetics of the fluorescence changes indicates that there are two conformations of IRIS-1 with a different FRET efficiency and only IRIS-1 with a low FRET efficiency is able to bind to IP3 (see the supplemental text). The kinetic parameters were estimated from both the kinetics data (Fig. S2 B) and the equilibrium data (Fig. S2 C) and were used to calculate the FRET changes during and after the addition of a brief pulse of IP3. The resting level of [IP3]c was configured to be 40 nM based on measurements in Xenopus laevis oocytes (Luzzi et al., 1998). Fig. S2 D shows the dynamics of the fraction of IRIS-1 with low FRET efficiency evoked by a 1-s pulse of various concentrations of IP3 (from 200 nM to 12.8 µM). The fraction of IRIS-1 with low FRET efficiency increased more than twofold 1 s after the onset of the IP3 pulses and returned to its basal level within 3 s after the IP3 pulses with all concentrations applied (Fig. S2 D). The frequency of the Ca2+ oscillations in the IRIS-1expressing cells stimulated with 100 µM glutamate was 36.9 ± 7.4 mHz (Fig. 3 B), and the mean duration of the interspike interval was 27.1 s. If [IP3]c actually returns to it basal level during the period of each Ca2+ spike, IRIS-1 would be able to monitor it. We therefore concluded that IRIS-1 possesses a sufficient temporal property to detect [IP3]c changes during Ca2+ oscillations evoked in HeLa cells.
Relationship between [IP3]c and [Ca2+]c during the rising phase of Ca2+ spikes
Spatiotemporal profiles of both [Ca2+]c and cytosolic [IP3] at the onset of initial Ca2+ spikes in HeLa cells after mGluR5a stimulation were monitored with the fast acquisition equipment (see Materials and methods). Images were acquired every 246 ms. Fig. 5
shows the spatiotemporal patterns of [Ca2+]c and [IP3]c when the first Ca2+ spike occurred. The rapid [Ca2+]c rise occurred in HeLa cells stimulated with 100 µM glutamate with little or no pacemaker Ca2+ rise (Fig. 5 B). No clear initiation site of the [Ca2+]c rise was detected in the cell shown (Fig. 5 A). The [IP3]c rise was found to precede the abrupt [Ca2+]c rise (Fig. 5, B and C) in 48 of 52 cells, and [IP3]c gradually rose almost homogeneously in the cells stimulated (Fig. 5 A). The onset of the [IP3]c rise, which was identified as an increase greater than twice the SD of the baseline signals, preceded the onset of the [Ca2+]c rise by 1.11 ± 1.75 s (n = 52). The rate of [IP3]c rise did not accelerate during the rising phase of the Ca2+ spike (Fig. 5, B and C, between c and e). If the regenerative IP3 production mediated by PLC drives the rising phase of Ca2+ spikes, the rate of [IP3]c rise should peak when the rate of [Ca2+]c rise is at its maximum. To test this possibility, the fluorescent signals of both Indo-1 and IRIS-1 were differentiated and aligned at the time when the rate of [Ca2+]c rise reached its maximum (Fig. 5, D and E). As shown in Fig. 5 E, the rate of [IP3]c rise did not peak when the rate of [Ca2+]c increase was at its maximum, indicating that the steep rise in [Ca2+]c occurred without any acceleration of the [IP3]c rise. A similar relationship was observed between [Ca2+]c and [IP3]c during the rising phases of the subsequent Ca2+ spikes (Fig. 6
). As reported in histamine-stimulated HeLa cells (Bootman and Berridge, 1996), the shape of the first and the subsequent Ca2+ spikes was different in mGluR5a-expressing HeLa cells stimulated with glutamate. The subsequent spikes had more extended pacemaker activity, and the rate of the [Ca2+]c rise after the pacemaker activity of the subsequent spikes was slower than that of the first spike (Fig. 6 A). As shown in Fig. 6, [IP3]c started to increase before the onset of the pacemaker [Ca2+]c rise of the second, third, and fourth Ca2+ spikes (filled and open arrowheads), and the [IP3]c increase did not accelerate during the period of the rapid [Ca2+]c rise of these Ca2+ spikes (between the thin vertical lines). The number of cells that showed [IP3]c rises preceding [Ca2+]c increases and the mean interval between the onset of the [IP3]c rise and the onset of the [Ca2+]c rise are summarized in Table S1 (available at http://www.jcb.org/cgi/content/full/jcb.200512141/DC1). These results suggest that regenerative IP3 production does not drive the abrupt Ca2+ increase of either the first or the subsequent Ca2+ spikes in mGluR5a-stimulated HeLa cells.
|
|
|
| Discussion |
|---|
|
|
|---|
Positive-feedback element that drives the steep rising phase of Ca2+ spikes
Meyer and Stryer (1988) proposed that cytosolic Ca2+ and IP3 are a pair of reciprocally coupled messengers based on evidence that IP3 induces cytosolic Ca2+ increase by triggering Ca2+ release from intracellular Ca2+ stores and that Ca2+ enhances IP3 production by activating PLC. Their model predicts that the cooperative opening of IP3R by the binding of multiple IP3 molecules and positive-feedback regulation of PLC by cytosolic Ca2+ lead to the bistability of the system (Meyer and Stryer, 1988) and that IP3 spikes in synchrony with Ca2+ spikes (we use "spike" to mean a threshold phenomenon characterized by an explosive rise and constant amplitude independent of stimulus intensity; Meyer and Stryer, 1988, 1991). We used the cytosolic IP3 sensor IRIS-1 to directly test the cross-coupling hypothesis in living HeLa cells and found that no IP3 spikes were detected during Ca2+ oscillations, according to the aforementioned definition, because the IRIS-1 signals did not exhibit an explosive rise during the rising phase of Ca2+ spikes (Figs. 5 and 6), and even when fluctuations were detected the absolute value of the peak level of fluctuations in IRIS-1 signals was not constant during Ca2+ oscillations evoked by mGluR5a stimulation (Figs. 4 and 6). The dynamic range of the IRIS-1 signals seems to be wider than the dynamic range of [IP3]c changes evoked by extracellular stimuli (Fig. S1 C), and the sevenfold lower IP3 binding affinity mutant of IRIS-1, IRIS-1.2, also failed to detect IP3 spikes (Fig. S1 E). The reaction of IRIS-1 is thought to be fast enough to detect [IP3]c changes during Ca2+ oscillations in mGluR5a-expressing HeLa cells, which exhibited 36.9 ± 7.4 mHz of Ca2+ oscillations (Fig. S2 D). Thus, the failure to detect IP3 spikes was not due to inability because of either the dynamic range or time resolution of IRIS-1. Fast acquisition of both Ca2+ and IP3 signals revealed that [IP3]c started to increase before the pacemaker rise in [Ca2+]c, and the abrupt increase in [Ca2+]c, which forms the rising phase of Ca2+ spikes, was not accompanied by a detectable acceleration in the [IP3]c increase (Figs. 5 and 6). The cytosolic Ca2+ increases actually induced IP3 production in HeLa cells without G proteincoupled receptor activation (Fig. 7 A), but it was a relatively slow process compared with the IP3 production evoked by histamine (Fig. 7 B). Receptor activation and [Ca2+]c increases have a synergistic effect on IP3 production, but it was not sufficiently strong to generate IP3 spikes even when [Ca2+]c was persistently elevated (Fig. 7 C). Although we cannot completely exclude the possibility that the local rapid rise in [IP3]c contributes to the generation of the rising phase of Ca2+ spikes, we used relatively small regions (Fig. 5 A), not the entire cytosol, to analyze the relationship between [Ca2+]c and [IP3]c and found that any acceleration in the [IP3]c increase was not detected in the region in which [Ca2+]c rose abruptly (Fig. 5, C and E). We therefore concluded that IP3 spikes do not occur during Ca2+ oscillations in HeLa cells and that the positive-feedback regulation of PLC by cytosolic Ca2+ is not a prime mechanism for the generation of the upstroke of Ca2+ spikes.
What is the positive-feedback element that drives the rising phase of Ca2+ spikes? One plausible mechanism is Ca2+-induced Ca2+ release (CICR) mediated by IP3R. IP3R is activated by cytosolic Ca2+, and positive-feedback regulation by cytosolic Ca2+ enables the Ca2+ released by one receptor to excite its neighbors, thereby igniting a regenerative Ca2+ wave. However, we did not test the CICR hypothesis in the present study. The CICR hypothesis needs to be evaluated more directly under native conditions in future studies.
Mechanisms of initiation of the steep rising phase of Ca2+ spikes
We found that [IP3]c started to increase before the pacemaker rise in [Ca2+]c and that the subsequent steep rise in [Ca2+]c was unaccompanied by any acceleration in the [IP3]c increase (Figs. 5 and 6). The individual abrupt [Ca2+]c rises of at least the first eight Ca2+ spikes were initiated at different concentrations of [IP3]c (Fig. 4 C), and the Ca2+ spikes of mGluR5a-expressing cells stimulated with 100 µM glutamate and cells stimulated with 3 µM histamine were triggered at different IP3 concentrations (Fig. 4 C). These results indicate that a constant threshold [IP3]c is not involved in the initiation of the steep Ca2+ rise in HeLa cells. What is the actual trigger for generation of the rapid upstroke of Ca2+ spikes? Numerous observations have shown that elevation of [IP3]c to submaximal levels causes only a transient, partial release of Ca2+, whereas further increments of [IP3]c evoke an additional transient Ca2+ release (Muallem et al., 1989; Taylor and Potter, 1990; Bootman et al., 1992; Ferris et al., 1992; Hirota et al., 1995; Yao et al., 1995). Subsequent elevations of [IP3]c yielded the same degree of Ca2+ release as the first [IP3]c elevation, and the retention of responsiveness has been called "incremental detection" (Meyer and Stryer, 1990). However, because we did not detect rapid increments in [IP3]c when the abrupt [Ca2+]c rises were triggered (Fig. 5, D and E), IP3-sensitive Ca2+ stores did not respond to the rate of [IP3]c increase in the cells examined. A time-dependent decrease in the IP3 binding affinity of IP3-gated Ca2+ release channels and/or multiple Ca2+ stores with different levels of IP3 sensitivity could account for this phenomenon. Ca2+ influx across plasma membranes might be involved in the initiation of repetitive spikes (Sneyd et al., 2004). Further analysis is required for the elucidation of the Ca2+ spike initiation mechanism.
IP3 metabolism in living cells
The mechanism underlying the generation of Ca2+ oscillations has been extensively investigated using various theoretical models. What kind of uncertainty is involved in such analyses? To address this issue, we tried to reproduce the experimental measurements of both IP3 and Ca2+ dynamics using a model based on previously reported models that incorporate the biphasic cytosolic Ca2+ dependency of IP3R and Ca2+ feedback on the production of IP3 (Meyer and Stryer, 1991; De Young and Keizer, 1992; Fig. S3, available at http://www.jcb.org/cgi/content/full/jcb.200512141/DC1). The model exhibited sharp Ca2+ oscillations accompanied by IP3 oscillations (Fig. S3, A and B) with the original parameters (Table S2; De Young and Keizer, 1992). When we compared the calculated trace of cytosolic IP3 with the experimental measurements (Fig. 4), the [IP3]c change predicted by the model was obviously too fast. We found that an
60-fold decrease in the rate of IP3 production (Fig. S3 E and Table S2) and a 30-fold decrease in the rate of IP3 degradation (Fig. S3 F and Table S2) produced reasonable [IP3]c changes (Fig. S3 C) accompanied by repetitive Ca2+ spikes (Fig. S3 D). The calculated Ca2+ dynamics (Fig. S3 D), however, were significantly different from the experimentally observed Ca2+ dynamics (Fig. 4) in terms of frequency and latency. Because the apparent IP3 sensitivity for the generation of Ca2+ spikes progressively decreases during Ca2+ oscillations (Fig. 4 C), this property must be incorporated into the IP3R model. It is clear that the actual IP3 metabolism in living cells is slower than previously estimated (Meyer and Stryer, 1991; De Young and Keizer, 1992). A similar conclusion was obtained from the estimation of the lifetime of IP3 in N1E-115 neuroblastoma cells (Wang et al., 1995).
Allbritton et al. (1992) proposed that Ca2+ is a local messenger, whereas IP3 is a global messenger based on their diffusion constants estimated in isolated cytosol. We propose that Ca2+ is a fast messenger and IP3 a slow messenger, based on the evidence that the concentration change of cytosolic IP3 is slower than that of Ca2+ in living cells. IP3R functions as a pulse generator in the signal transduction cascade that translates the information from the slow IP3 signal to the fast Ca2+ signal. Elucidation of the encoding algorithm of this signal conversion is the next challenge in terms of better understanding the molecular basis of Ca2+ signaling.
| Materials and methods |
|---|
|
|
|---|
Gene construction
The IP3 binding core cDNA was obtained by PCR from pBact-ST-neoB-C1 (Furuichi et al., 1989; Miyawaki et al., 1990). Venus (Nagai et al., 2002) and ECFP cDNAs were fused to the 5' and the 3' end, respectively, of the IP3 binding domain to produce IRIS proteins. Mutations of T267A and K508Q or K249Q were introduced as described elsewhere (Sawano and Miyawaki, 2000) to create an IP3 bindingdeficient mutant and a low IP3 bindingaffinity mutant, respectively. IP3 sensor cDNAs were cloned in BamHI and XhoI sites of pcDNA3.1 zeo(+) (Invitrogen) that contains 6x Histidine tag (Fig. 1 A) in NheI to HindIII site for the expression in mammalian cells. The multicloning site of pcDNA3.1 zeo(+) was amplified by PCR and cloned into SalI site of pFastBacI (Invitrogen). IRIS-1 and IRIS-1Dmut were digested by NheI and XhoI from pcDNA3.1 zeo(+) and inserted to the modified pFastBacI for the expression in Sf9 cells. Venus or ECFP cDNA was fused to 5' end of cDNA corresponding to amino acid residues 11140 of rat PLC
1 to create V-PHD (provided by M. Hattori, Nagoya City University, Aichi, Japan) and C-PHD, respectively. The resulting cDNAs were cloned in pcDNA3.1 zeo(+). Rat mGluR5a cDNA inserted into pME18S (Kawabata et al., 1996) was a gift from S. Nakanishi (Osaka Bioscience Institute, Osaka, Japan).
Expression, purification, and characterization in vitro
In vitro characterization of IRIS proteins were performed by using lysates prepared from COS7 or Sf9 cells expressing IRIS proteins and IRIS proteins purified from Sf9 cells. COS7 cells expressing IRIS proteins were lysed with the solution containing 10 mM Hepes, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM 2-mercaptoethanol, and 0.5% NP-40. His-tagged IRIS-1 and IRIS-1Dmut proteins were expressed by means of Sf9 baculovirusexpressing system (Invitrogen) and were purified as follows. Sf9 cells were suspended in homogenization solution containing 10 mM Hepes, pH 7.8, 100 mM NaCl, 5 mM 2-mercaptoethanol, 0.1% NP-40, and proteinase inhibitors (0.1 mM PMSF, 10 µM Leupeptin, 10 µM Pepstatin A, and 10 µM E60) and were homogenized at 1,000 rpm for 10 strokes at 4°C. Homogenates were applied to Probond resin (Invitrogen), and His-tagged proteins were eluted with 300 mM imidazole. Proteins were then dialyzed for 30 min against the solution containing 10 mM Hepes, pH 7.4, and 100 mM KCl. The dialyzed proteins were loaded to HiTrap heparin columns and eluted with the high KCl solution containing 10 mM Hepes, pH 7.4, and 250 mM KCl. Proteins were diluted by adding two volumes of the solution containing 10 mM Hepes, pH 7.4, and 100 mM KCl and concentrated with centrifugal filter devices (30,000 MWCO; Amicon Ultra 15 [Millipore]). For the evaluation of the rate of changes in IRIS-1 signals, IRIS-1expressing Sf9 cells were suspended in 10 mM Hepes, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM 2-mercaptoethanol, 0.01% NP-40, and proteinase inhibitors and were homogenized at 1,000 rpm for 10 strokes at 4°C. The homogenates were centrifuged at 20,000 g for 30 min, and the supernatants were used for stopped-flow fluorescent measurements. The number of IRIS-1 molecules in the supernatants was quantified by the equilibrium IP3 binding analysis using [3H]IP3 as described previously (Iwai et al., 2005). IRIS signals were measured with a spectrofluorometer (FP-750; Jasco).
Imaging
IRIS cDNAs inserted in pcDNA3.1 zeo(+) were transfected into HeLa cells with transfection reagents (TransIT; Mirus). After 1236 h, cells were used for imaging. After loading the cells with 5 µM Indo-1 AM (DOJINDO), imaging was performed under the constant flow (2 ml/min) of the balanced salt solution containing 20 mM Hepes, pH 7.4, 115 mM NaCl, 5.4 mM KCl, 1 mM MgCl2, 2 mM CaCl 2, and 10 mM glucose as an imaging media at 37°C. Imaging was performed at 37°C through an inverted microscope (IX-71 or IX-81; Olympus) with a cooled charge-coupled device camera (ORCA-ER; Hamamatsu Photonics) and a 40x (NA 1.35) objective. A 333348-nm excitation filter and pair of 420440- and 460510-nm emission filters and a 425445-nm excitation and pair of 460510-nm (cyan) and 525565-nm (yellow) emission filters were used for fluorochromes (Indo-1 and IRIS, respectively). Beam-splitter mirrors (400 and 450 nm) were alternately inserted into the light path for Indo-1 and IRIS, respectively. Images were acquired at 0.25 Hz, with an exposure time of 100 or 150 ms. For the fast acquisition (4.07 Hz) of fluorescent images of IRIS-1 and Indo-1, an emission splitter (W-view; Hamamatsu Photonics) was used with a fast light source exchanger (DG-4; Sutter Instrument Co.) on the IX71 inverted microscope. Sequential excitation of IRIS-1 and Indo-1 was performed by using a 450-nm dichroic mirror and two excitation filters (a 425445-nm filter for IRIS-1 and a 333348-nm filter for Indo-1). Dual emission at 460490 nm (for IRIS-1 and Indo-1) and >520 nm (for IRIS-1) split with a 460490-nm filter, a long-path 520-nm barrier filter, and two 505-nm dichroic mirrors equipped in W-view. Images were acquired at 4.07 Hz, with an exposure time of 100 or 150 ms. Acquisition was performed with the custom software TI Workbench (written by T. Inoue). Off-line analysis was performed with TI Workbench combined with Igor Pro software (WaveMetrics). Spectral analysis of Ca2+ oscillations was performed as described previously (Uhlen, 2004).
Stopped-flow fluorescent measurement
The change in the intensity of Venus fluorescence (525 ± 20 nm) of IRIS-1 after the addition of various concentrations of IP3 was monitored using the FP-750 spectrofluorometer with a stopped-flow rapid mixing accessory (RX2000; Applied Photophysics). The IRIS-1containing supernatants (final 2.5 nM of IRIS-1) were mixed with a 24-foldexcess volume of 10 mM Hepes, pH 7.4, 100 mM NaCl, 1 mM EDTA, 1 mM 2-mercaptoethanol, and 0.01% NP-40 containing various concentrations of IP3 at 25°C, and the change of the intensity of Venus fluorescence of IRIS-1 excited at 440 ± 20 nm was monitored at 1,000 Hz. At least 10 traces were averaged and were used for the nonlinear regression analysis with Igor Pro software. The IP3 dependency of FRET changes of IRIS-1 at equilibrium was monitored using the same batches of the supernatants as used for the kinetic measurements with a 1-cm cuvette and the FP-750 spectrofluorometer.
Online supplemental material
Fig. S1 shows effects of PLC inhibitors on emission changes of IRIS-1 elicited by 10 µM of histamine and evaluation of IRIS-1 signals observed in living HeLa cells. Fig. S2 shows the rate of reaction of IRIS-1. Fig. S3 shows simulation of IP3 and Ca2+ dynamics. Table S1 shows numbers of cells that showed [IP3]c rises preceding [Ca2+]c increases, the mean intervals between the onset of [IP3]c rises, and the onset of [Ca2+]c rises. Table S2 shows the parameters used to calculate IP3 and Ca2+ dynamics. The supplemental text shows evaluation of the effect of the rate of FRET changes of IRIS-1 upon IP3 binding. Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.200512141/DC1.
| Acknowledgments |
|---|
This work was supported by The 21st Century Center of Excellence program, the Center for Integrated Brain Medical Science, and grants from the Ministry of Education, Culture, Sports, Science and Technology of Japan to T. Matsu-ura (18770144), T. Michikawa (17017013 and 17570128), and T. Inoue and K. Mikoshiba (15100006); the Ministry of Health, Labor and Welfare to T. Inoue; and the Moritani Scholarship Foundation to T. Michikawa.
Submitted: 27 December 2005
Accepted: 3 May 2006
| References |
|---|
|
|
|---|
Allbritton, N.L., T. Meyer, and L. Stryer. 1992. Range of messenger action of calcium ion and inositol 1,4,5-trisphosphate. Science. 258:18121815.
Berridge, M.J. 1988. Inositol trisphosphate-induced membrane potential oscillations in Xenopus oocytes. J. Physiol. 403:589599.
Berridge, M.J., and G. Dupont. 1994. Spatial and temporal signalling by calcium. Curr. Opin. Cell Biol. 6:267274.[CrossRef][Medline]
Berridge, M.J., P. Lipp, and M.D. Bootman. 2000. The versatility and universality of calcium signalling. Nat. Rev. Mol. Cell Biol. 1:1121.[CrossRef][Medline]
Bootman, M.D., and M.J. Berridge. 1996. Subcellular Ca2+ signals underlying waves and graded responses in HeLa cells. Curr. Biol. 6:855865.[CrossRef][Medline]
Bootman, M.D., M.J. Berridge, and C.W. Taylor. 1992. All-or-nothing Ca2+ mobilization from the intracellular stores of single histamine-stimulated HeLa cells. J. Physiol. 450:163178.
Bosanac, I., J.R. Alattia, T.K. Mal, J. Chan, S. Talarico, F.K. Tong, K.I. Tong, F. Yoshikawa, T. Furuichi, M. Iwai, et al. 2002. Structure of the inositol 1,4,5-trisphosphate receptor binding core in complex with its ligand. Nature. 420:696700.[CrossRef][Medline]
Cobbold, P.H., A. Sanchez-Bueno, and C.J. Dixon. 1991. The hepatocyte calcium oscillator. Cell Calcium. 12:8795.[CrossRef][Medline]
De Young, G.W., and J. Keizer. 1992. A single-pool inositol 1,4,5-trisphosphate-receptor-based model for agonist-stimulated oscillations in Ca2+ concentration. Proc. Natl. Acad. Sci. USA. 89:98959899.
Dupont, G., M.J. Berridge, and A. Goldbeter. 1991. Signal-induced Ca2+ oscillations: properties of a model based on Ca2+-induced Ca2+ release. Cell Calcium. 12:7385.[CrossRef][Medline]
Ferris, C.D., A.M. Cameron, R.L. Huganir, and S.H. Snyder. 1992. Quantal calcium release by purified reconstituted inositol 1,4,5-trisphosphate receptors. Nature. 356:350352.[CrossRef][Medline]
Furuichi, T., S. Yoshikawa, A. Miyawaki, K. Wada, N. Maeda, and K. Mikoshiba. 1989. Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature. 342:3238.[CrossRef][Medline]
Hajnoczky, G., and A.P. Thomas. 1997. Minimal requirements for calcium oscillations driven by the IP3 receptor. EMBO J. 16:35333543.[CrossRef][Medline]
Harootunian, A.T., J.P. Kao, S. Paranjape, and R.Y. Tsien. 1991. Generation of calcium oscillations in fibroblasts by positive feedback between calcium and IP3. Science. 251:7578.
Hirose, K., S. Kadowaki, M. Tanabe, H. Takeshima, and M. Iino. 1999. Spatiotemporal dynamics of inositol 1,4,5-trisphosphate that underlies complex Ca2+ mobilization patterns. Science. 284:15271530.
Hirota, J., T. Michikawa, A. Miyawaki, T. Furuichi, I. Okura, and K. Mikoshiba. 1995. Kinetics of calcium release by immunoaffinity-purified inositol 1,4,5-trisphosphate receptor in reconstituted lipid vesicles. J. Biol. Chem. 270:1904619051.
Iino, M. 1990. Biphasic Ca2+ dependence of inositol 1,4,5-trisphosphate-induced Ca release in smooth muscle cells of the guinea pig taenia caeci. J. Gen. Physiol. 95:11031122.
Iino, M., T. Yamazawa, Y. Miyashita, M. Endo, and H. Kasai. 1993. Critical intracellular Ca2+ concentration for all-or-none Ca2+ spiking in single smooth muscle cells. EMBO J. 12:52875291.[Medline]
Irvine, R. 2004. Inositol lipids: to PHix or not to PHix? Curr. Biol. 14:R308R310.[CrossRef][Medline]
Iwai, M., Y. Tateishi, M. Hattori, A. Mizutani, T. Nakamura, A. Futatsugi, T. Inoue, T. Furuichi, T. Michikawa, and K. Mikoshiba. 2005. Molecular cloning of mouse type 2 and type 3 inositol 1,4,5-trisphosphate receptors and identification of a novel type 2 receptor splice variant. J. Biol. Chem. 280:1030510317.
Iwasaki, H., K. Chiba, T. Uchiyama, F. Yoshikawa, F. Suzuki, M. Ikeda, T. Furuichi, and K. Mikoshiba. 2002. Molecular characterization of the starfish inositol 1,4,5-trisphosphate receptor and its role during oocyte maturation and fertilization. J. Biol. Chem. 277:27632772.
Jacob, R., J.E. Merritt, T.J. Hallam, and T.J. Rink. 1988. Repetitive spikes in cytoplasmic calcium evoked by histamine in human endothelial cells. Nature. 335:4045.[CrossRef][Medline]
Kawabata, S., R. Tsutsumi, A. Kohara, T. Yamaguchi, S. Nakanishi, and M. Okada. 1996. Control of calcium oscillations by phosphorylation of metabotropic glutamate receptors. Nature. 383:8992.[CrossRef][Medline]
Lechleiter, J., S. Girard, E. Peralta, and D. Clapham. 1991. Spiral calcium wave propagation and annihilation in Xenopus laevis oocytes. Science. 252:123126.
Luzzi, V., C.E. Sims, J.S. Soughayer, and N.L. Allbritton. 1998. The physiologic concentration of inositol 1,4,5-trisphosphate in the oocytes of Xenopus laevis. J. Biol. Chem. 273:2865728662.
Meyer, T., and L. Stryer. 1988. Molecular model for receptor-stimulated calcium spiking. Proc. Natl. Acad. Sci. USA. 85:50515055.
Meyer, T., and L. Stryer. 1990. Transient calcium release induced by successive increments of inositol 1,4,5-trisphosphate. Proc. Natl. Acad. Sci. USA. 87:38413845.
Meyer, T., and L. Stryer. 1991. Calcium spiking. Annu. Rev. Biophys. Biophys. Chem. 20:153174.[CrossRef][Medline]
Michikawa, T., J. Hirota, S. Kawano, M. Hiraoka, M. Yamada, T. Furuichi, and K. Mikoshiba. 1999. Calmodulin mediates calcium-dependent inactivation of the cerebellar type 1 inositol 1,4,5-trisphosphate receptor. Neuron. 23:799808.[CrossRef][Medline]
Miyawaki, A., T. Furuichi, N. Maeda, and K. Mikoshiba. 1990. Expressed cerebellar-type inositol 1,4,5-trisphosphate receptor, P400, has calcium release activity in a fibroblast L cell line. Neuron. 5:1118.[CrossRef][Medline]
Miyawaki, A., T. Furuichi, Y. Ryou, S. Yoshikawa, T. Nakagawa, T. Saitoh, and K. Mikoshiba. 1991. Structure-function relationships of the mouse inositol 1,4,5-trisphosphate receptor. Proc. Natl. Acad. Sci. USA. 88:49114915.
Muallem, S., S.J. Pandol, and T.G. Beeker. 1989. Hormone-evoked calcium release from intracellular stores is a quantal process. J. Biol. Chem. 264:205212.
Nagai, T., K. Ibata, E.S. Park, M. Kubota, K. Mikoshiba, and A. Miyawaki. 2002. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20:8790.[CrossRef][Medline]
Nash, M.S., M.J. Schell, P.J. Atkinson, N.R. Johnston, S.R. Nahorski, and R.A. Challiss. 2002. Determinants of metabotropic glutamate receptor-5-mediated Ca2+ and inositol 1,4,5-trisphosphate oscillation frequency. Receptor density versus agonist concentration. J. Biol. Chem. 277:3594735960.
Osipchuk, Y.V., M. Wakui, D.I. Yule, D.V. Gallacher, and O.H. Petersen. 1990. Cytoplasmic Ca2+ oscillations evoked by receptor stimulation, G-protein activation, internal application of inositol trisphosphate or Ca2+: simultaneous microfluorimetry and Ca2+ dependent Cl current recording in single pancreatic acinar cells. EMBO J. 9:697704.[Medline]
Prentki, M., M.C. Glennon, A.P. Thomas, R.L. Morris, F.M. Matschinsky, and B.E. Corkey. 1988. Cell-specific patterns of oscillating free Ca2+ in carbamylcholine-stimulated insulinoma cells. J. Biol. Chem. 263:1104411047.
Rebecchi, M.J., and S.N. Pentyala. 2000. Structure, function, and control of phosphoinositide-specific phospholipase C. Physiol. Rev. 80:12911335.
Remus, T.P., A.V. Zima, J. Bossuyt, D.J. Bare, J.L. Martin, L.A. Blatter, D.M. Bers, and G.A. Mignery. 2006. Biosensors to measure inositol 1,4,5-trisphosphate concentration in living cells with spatiotemporal resolution. J. Biol. Chem. 281:608616.
Sato, M., Y. Ueda, M. Shibuya, and Y. Umezawa. 2005. Locating inositol 1,4,5-trisphosphate in the nucleus and neuronal dendrites with genetically encoded fluorescent indicators. Anal. Chem. 77:47514758.[Medline]
Sawano, A., and A. Miyawaki. 2000. Directed evolution of green fluorescent protein by a new versatile PCR strategy for site-directed and semi-random mutagenesis. Nucleic Acids Res. 28:E78.[CrossRef][Medline]
Sneyd, J., K. Tsaneva-Atanasova, D.I. Yule, J.L. Thompson, and T.J. Shuttleworth. 2004. Control of calcium oscillations by membrane fluxes. Proc. Natl. Acad. Sci. USA. 101:13921396.
Tanimura, A., A. Nezu, T. Morita, R.J. Turner, and Y. Tojyo. 2004. Fluorescent biosensor for quantitative real-time measurements of inositol 1,4,5-trisphosphate in single living cells. J. Biol. Chem. 279:3809538098.
Taylor, C.W., and B.V. Potter. 1990. The size of inositol 1,4,5-trisphosphate-sensitive Ca2+ stores depends on inositol 1,4,5-trisphosphate concentration. Biochem. J. 266:189194.[Medline]
Thomas, A.P., D.C. Renard, and T.A. Rooney. 1991. Spatial and temporal organization of calcium signalling in hepatocytes. Cell Calcium. 12:111126.[CrossRef][Medline]
Uchiyama, T., F. Yoshikawa, A. Hishida, T. Furuichi, and K. Mikoshiba. 2002. A novel recombinant hyperaffinity inositol 1,4,5-trisphosphate (IP3) absorbent traps IP3, resulting in specific inhibition of IP3-mediated calcium signaling. J. Biol. Chem. 277:81068113.